Diabetes Drug Ozempic

Novo Nordisk’s Ozempic Gets FDA Approval

FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a gradual loss of kidney function.

CNN on MSN · 1d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

Forbes on MSN · 1d

Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and strokes.

2hon MSN

Amy Schumer lost 30 pounds on Ozempic: Why she stopped taking it

I have this gene, GDF15, which makes you extremely prone to nausea, which is why i was so sick during my pregnancy,” the actress told Howard Stern on his radio show.

Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

6don MSN

Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

11d

Ozempic, Wegovy among drugs selected for Medicare's price negotiations

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

3don MSN

Ozempic, Wegovy may help mental health, substance disorders

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results